NuGen Medical Devices (TSXV:NGMD) ROCE % : -198.58% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NuGen Medical Devices ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NuGen Medical Devices's annualized ROCE % for the quarter that ended in Dec. 2023 was -198.58%.

NuGen Medical Devices ROCE % Historical Data

The historical data trend for NuGen Medical Devices's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuGen Medical Devices ROCE % Chart

NuGen Medical Devices Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

-62.07

-94.68

-71.68

-184.45

NuGen Medical Devices Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial								-69.17	-107.05	-148.45	-166.30	-198.58

NuGen Medical Devices ROCE % Calculation

NuGen Medical Devices's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-8.092	/	( ( (6.849 - 1.73)	+	(6.946 - 3.291) )	/ 2 )
	=	-8.092	/	( (5.119	+	3.655)	/ 2 )
	=	-8.092	/	4.387
	=	-184.45 %

NuGen Medical Devices's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-8.944	/	( ( (8.524 - 3.171)	+	(6.946 - 3.291) )	/ 2 )
	=	-8.944	/	( ( 5.353	+	3.655 )	/ 2 )
	=	-8.944	/	4.504
	=	-198.58 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

NuGen Medical Devices (TSXV:NGMD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

NuGen Medical Devices ROCE % Related Terms

Thank you for viewing the detailed overview of NuGen Medical Devices's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

NuGen Medical Devices (TSXV:NGMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (TSXV:NGMD) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

NGMDF:USA 79O:Germany

Address

18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4

Website

https://www.nugenmd.com

NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needless injector devices. Geographically the company generates revenue from Asia, Europe and others.

Executives

Richard Buzbuzian

Director, Senior Officer

NuGen Medical Devices (TSXV:NGMD) Headlines

No Headlines